Reuters logo
BRIEF-Protalix Biotherapeutics says last patient enrolled in mid-stage trial
December 22, 2016 / 12:48 PM / 9 months ago

BRIEF-Protalix Biotherapeutics says last patient enrolled in mid-stage trial

Dec 22 (Reuters) - Protalix Biotherapeutics Inc :

* Protalix Biotherapeutics - expects to report interim top-line results from study during first week of Jan 2017, and full results before end of Q1 of 2017

* Protalix Biotherapeutics announces last patient enrolled in the Air Dnase phase II clinical trial for cystic fibrosis Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below